Weigl Daniel M, Arbel Nili, Katz Kalman, Becker Tali, Bar-On Elhanan
Pediatric Orthopedic Unit, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel.
J Pediatr Orthop B. 2007 Jul;16(4):293-6. doi: 10.1097/BPB.0b013e328092562b.
Forty patients (mean age 5 years) with a spastic disorder treated by botulinum injections (53 sessions) were evaluated for functional outcome in terms of achievement of their individual predetermined goals of treatment, rated on a modified Goal Attainment Scale from 1 (worsening function) to 4 (improved gross motor function). At the 2-week follow-up, 40% had a score of 1, 33% a score of 2, and 13% a score of 3; 12% showed no functional change. Botulinum treatments failed to significantly improve the gross motor function in this patient group. Treatment goals and expectations should clearly be established beforehand.
对40例(平均年龄5岁)接受肉毒杆菌注射治疗(共53次疗程)的痉挛性疾病患者,根据其个人预定治疗目标的达成情况评估功能转归,采用改良的目标达成量表进行评分,评分范围为1分(功能恶化)至4分(粗大运动功能改善)。在2周的随访中,40%的患者评分为1分,33%评分为2分,13%评分为3分;12%的患者功能无变化。肉毒杆菌治疗未能显著改善该患者组的粗大运动功能。治疗目标和期望应提前明确确立。